SENOMAC-ULTRA Trial Comparing Targeted Axillary Dissection and Full Lymph Node Removal in Breast Cancer with Pre-Surgery Detected Lymph Node Spread
Led by Karolinska Institutet · Updated on 2026-08-17
1380
Participants Needed
4
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying breast cancer patients who have cancer spread to lymph nodes in the armpit detected before surgery by imaging. The trial aims to compare two surgical methods the standard full axillary lymph node dissection, which removes many lymph nodes, and a less extensive approach called targeted axillary dissection TAD that removes only the first lymph nodes and known metastatic nodes. This study focuses on whether the less extensive surgery can provide similar survival outcomes while reducing complications.
Participants will be randomly assigned to one of two surgery groups the standard surgery removing about 10 or more lymph nodes, or the targeted surgery removing marked metastatic nodes plus sentinel lymph nodes. The study follows patients over several years to assess the outcomes of these surgical approaches.
During the study, participants will be monitored for recurrence-free survival over 5 years, as well as arm-related problems, overall survival, and quality of life at 1, 3, and 5 years. The research team will collect health data and evaluate arm function and quality of life to understand the impact of the surgery type chosen. The total study duration extends up to 15 years, including follow-up and long-term monitoring.
CONDITIONS
Brief Title
Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer
Research Team
J
Jana de Boniface, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with primary invasive breast cancer clinical stage II-III
Axillary metastases confirmed by ultrasound and biopsy
Written informed consent provided
Age 18 years or older
You will not qualify if you...
Presence of distant metastases
Metastases in internal mammary, infra- or supraclavicular lymph nodes without axillary nodal involvement
Suspicion of extensive nodal involvement before surgery
Nodes fixed to each other or nearby structures
History of invasive breast cancer in the opposite breast within 5 years
Bilateral invasive breast cancer if one side meets exclusion or both sides meet inclusion criteria
Pregnancy
Neoadjuvant systemic treatment longer than 3 months
Medical reasons preventing radiotherapy or standard adjuvant systemic treatment
Inability to understand study information due to disability, language, or dementia
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Single surgery event
Participants undergo either full axillary lymph node dissection or targeted axillary dissection removing marked metastases and sentinel lymph nodes.
Surgery visit and follow-up visits as scheduled
Follow-up
Duration - 5 years
Participants are monitored for recurrence, arm function, quality of life, and overall survival over 5 years.
Regular follow-up visits at 1, 3, and 5 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Studying Key Non-coding RNAs and Their Interaction With Chromatin Remodeling in Breast Cancer Patients
Comparing 18F-FDG and 68Ga-FAPI-46 PET Scans in Women With ER-positive Breast Cancer
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Early Phase 1 Study of 3D Ultrasound Imaging for Breast Cancer Lymph Nodes
Observational Study Comparing 3D and 2D Echocardiography for Early Heart Damage Detection in Patients Receiving Anthracyclines and HER2-Targeted Cancer Therapies
Study Comparing 3D-Printed Biodegradable Breast Implants, Traditional Breast-Conserving Surgery, and Silicone Implant Reconstruction for Breast Cancer Patients
Ultrahypofractionated 5-Session Whole Breast Radiotherapy with Boost versus Standard 15-Session Radiotherapy for Breast Cancer Patients with Unfavorable Characteristics
Phase II Study Comparing 5-Day vs. 9-Day Whole Breast Radiotherapy with Boost in Early-stage Breast Cancer
Evaluating 68Ga-FAPI PETCT for Checking Axillary Lymph Node Status After Neoadjuvant Therapy in Women with Breast Cancer
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.